← Eichor
Study identifier: NCT06614595 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Condition: Low Risk Myelodysplastic Syndromes  ·  Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Observational study to evaluate changes in quality of life (QoL) in patients diagnosed with low risk MDS who are red blood cell (abc) transfusion dependent. Changes in QoL will be correlated with patient cardiorespiratory function. Cardiac biomarkers and plasma cytokines will also be evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Teresa Bernal del Castillo  ·  985108000  ·  bernaldelcastillo@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Universitario Central de AsturiasOviedo, Principality of Asturias, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06614595